Skip to Main Content

Paper Details

A suite of automated sequence analyses reduces the number of candidate deleterious variants and reveals a difference between probands and unaffected siblings.
Genet Med
6
2019
Author NameAffiliation
May Christine V MalicdanOffice of the Clinical Director, National Human Genome Research Institute, National Institutes of Health
May Christine V MalicdanOffice of the Clinical Director, National Human Genome Research Institute, National Institutes of Health
David R AdamsOffice of the Clinical Director, National Human Genome Research Institute, National Institutes of Health
David R AdamsOffice of the Clinical Director, National Human Genome Research Institute, National Institutes of Health
Cynthia J TifftOffice of the Clinical Director, National Human Genome Research Institute, National Institutes of Health
Cynthia J TifftOffice of the Clinical Director, National Human Genome Research Institute, National Institutes of Health
Camilo ToroOffice of the Clinical Director, National Human Genome Research Institute, National Institutes of Health
William A GahlOffice of the Clinical Director, National Human Genome Research Institute, National Institutes of Health
William A GahlOffice of the Clinical Director, National Human Genome Research Institute, National Institutes of Health
Thomas C MarkelloOffice of the Clinical Director, National Human Genome Research Institute, National Institutes of Health
  • 1 - 10

Datasets